[go: up one dir, main page]

WO2001077335A3 - Genome de listeria monocytogenes, polypeptides et utilisations - Google Patents

Genome de listeria monocytogenes, polypeptides et utilisations Download PDF

Info

Publication number
WO2001077335A3
WO2001077335A3 PCT/FR2001/001118 FR0101118W WO0177335A3 WO 2001077335 A3 WO2001077335 A3 WO 2001077335A3 FR 0101118 W FR0101118 W FR 0101118W WO 0177335 A3 WO0177335 A3 WO 0177335A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
concerns
listeria monocytogenes
sequences
monocytogenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2001/001118
Other languages
English (en)
Other versions
WO2001077335A2 (fr
Inventor
Carmen Buchrieser
Lionel Frangeul
Elisabeth Couve
Christophe Rusniok
Hafida Fsihi
Pierre Dehoux
Olivier Dussurget
Farid Chetouani
Hafed Nedjari
Philippe Glaser
Frank Kunst
Pascale Cossart
Justin Daniels
Werner Goebel
Juergen Kreft
Michael Kuhn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to EP01927973A priority Critical patent/EP1278853A2/fr
Priority to JP2001575189A priority patent/JP2004507217A/ja
Priority to CA002404988A priority patent/CA2404988A1/fr
Priority to AU2001254857A priority patent/AU2001254857A1/en
Publication of WO2001077335A2 publication Critical patent/WO2001077335A2/fr
Publication of WO2001077335A3 publication Critical patent/WO2001077335A3/fr
Anticipated expiration legal-status Critical
Priority to US11/045,004 priority patent/US20060078901A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

La présente invention concerne la séquence génomique et des séquences nucléotidiques de Listeria monocytogenes EGD-e. L'invention a également pour objet les polypeptides de cet organisme, en particulier les polypeptides de surface ou d'enveloppe cellulaire, ou impliqués dans les différents cycles de métabolisme, en particulier la biosynthèse de vitamine B12. L'invention concerne aussi les utilisations des séquences décrites, ainsi que différents outils permettant l'identification de L. monocytogenes ou espèces associées. L'invention concerne ausi des souches L. monocytogenes modifiées, ainsi que les compositions pharmaceutiques ou vaccinales utilisant les séquences de l'invention.
PCT/FR2001/001118 2000-04-11 2001-04-11 Genome de listeria monocytogenes, polypeptides et utilisations Ceased WO2001077335A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP01927973A EP1278853A2 (fr) 2000-04-11 2001-04-11 Genome de listeria monocytogenes, polypeptides et utilisations
JP2001575189A JP2004507217A (ja) 2000-04-11 2001-04-11 リステリア菌ゲノム、ポリペプチドおよびその使用
CA002404988A CA2404988A1 (fr) 2000-04-11 2001-04-11 Genome de listeria monocytogenes, polypeptides et utilisations
AU2001254857A AU2001254857A1 (en) 2000-04-11 2001-04-11 Listeria monocytogenes genome, polypeptides and uses
US11/045,004 US20060078901A1 (en) 2000-04-11 2005-01-28 Listeria monocytogenes genome, polypeptides and uses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0004629 2000-04-11
FR00/04629 2000-04-11

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10257023 A-371-Of-International 2001-04-11
US63765703A Continuation 2000-04-11 2003-08-11

Publications (2)

Publication Number Publication Date
WO2001077335A2 WO2001077335A2 (fr) 2001-10-18
WO2001077335A3 true WO2001077335A3 (fr) 2002-09-12

Family

ID=8849123

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/001118 Ceased WO2001077335A2 (fr) 2000-04-11 2001-04-11 Genome de listeria monocytogenes, polypeptides et utilisations

Country Status (6)

Country Link
US (1) US20060078901A1 (fr)
EP (1) EP1278853A2 (fr)
JP (1) JP2004507217A (fr)
AU (1) AU2001254857A1 (fr)
CA (1) CA2404988A1 (fr)
WO (1) WO2001077335A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
EA004444B1 (ru) 1998-12-22 2004-04-29 Майкросайенс Лимитед Гены и белки и их применение
US7125698B2 (en) 1999-08-09 2006-10-24 Matthew Glenn Polynucleotides, materials incorporating them, and methods for using them
AU2001284558B2 (en) 2000-08-08 2007-01-04 Genesis Research And Development Corporation Limited Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
FR2814754B1 (fr) * 2000-10-04 2005-09-09 Pasteur Institut Listeria innocua, genome et applications
AU2003218833A1 (en) * 2002-03-11 2003-09-22 Wageningen Centre For Food Sciences Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance
WO2003102168A1 (fr) * 2002-05-29 2003-12-11 The Regents Of The University Of California Listeria spp. attenuee et leurs methodes d'utilisation
GB0223737D0 (en) * 2002-10-11 2002-11-20 Plant Bioscience Ltd A Promoter from streptomyces coelicolor
US7368547B2 (en) * 2003-02-03 2008-05-06 Mississippi State University Use of novel virulence-specific genes as targets for diagnosis and potential control of virulent strains of Listeria monocytogenes
GB0308198D0 (en) * 2003-04-09 2003-05-14 Chiron Srl ADP-ribosylating bacterial toxin
EP1629005A2 (fr) * 2003-05-30 2006-03-01 Intercell AG Antigenes d'enterococcus
US20060217308A1 (en) * 2005-03-10 2006-09-28 Pascale Cossart Compositions for the treatment of tumor pathologies, comprising internalin B (ln1B) of Listeria monocytogene protein or a fragment thereof
EP2044218A2 (fr) * 2006-07-21 2009-04-08 Hitachi Chemical Company, Ltd. Ligands d'acide nucleique aptes a se lier a l'internaline b ou l'internaline a
US7645582B2 (en) * 2006-07-21 2010-01-12 Hitachi Chemical Co., Ltd. Aptamers that bind to listeria surface proteins
ES2298055A1 (es) * 2006-08-09 2008-05-01 Fundacion Marques De Valdecilla Peptidos inmunogenicos frente a los generos listeria y mycobacterium, anticuerpos y usos de los mismos.
WO2008066774A2 (fr) 2006-11-22 2008-06-05 The Regents Of The University Of California Souches de listéria modulant la production d'interféron-bêta et procédés d'utilisation de celles-ci
EP1935984A1 (fr) * 2006-12-20 2008-06-25 Unilever N.V. Procédé d'assistance à la conduite et appareil d'assistance à la conduite
EP2173881B1 (fr) * 2007-07-23 2016-09-28 DSM IP Assets B.V. Enzymes productrices d'acétyl-coa dans la levure
WO2009025846A2 (fr) 2007-08-22 2009-02-26 The Regents Of The University Of California Polypeptides de liaison activables et procédés d'identification et utilisation de ceux-ci
WO2009101737A1 (fr) * 2008-02-14 2009-08-20 Osaka University Vecteur d'expression de protéine marqué par un peptide ayant un résidu de méthionine
RU2636046C2 (ru) 2009-01-12 2017-11-17 Сайтомкс Терапьютикс, Инк Композиции модифицированных антител, способы их получения и применения
EP2398494A4 (fr) 2009-02-23 2015-10-28 Cytomx Therapeutics Inc Proprotéines et leurs procédés d'utilisation
BR112012004546A8 (pt) 2009-08-29 2017-12-05 Abbott Lab Terapêutica por proteínas ligantes dll4-ligantes
SG10201501562VA (en) * 2010-03-02 2015-04-29 Abbvie Inc Therapeutic dll4 binding proteins
EP2588628A1 (fr) 2010-06-30 2013-05-08 Life Technologies Corporation Détection d'espèces listeria dans des échantillons alimentaires et environnementaux et procédés et compositions afférents
WO2016069888A1 (fr) 2014-10-29 2016-05-06 University Of Wyoming Compositions et procédés de production et d'utilisation d'enzymes hydrolytiques pour la dégradation de polysaccharides produits par des bactéries pathogènes d'origine alimentaire
WO2016073854A1 (fr) * 2014-11-07 2016-05-12 Avidbiotics Corp. Monocines et procédés d'utilisation
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
JP7210029B2 (ja) * 2016-11-16 2023-01-23 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ＣＲＩＳＰＲ－Ｃａｓ９の阻害因子
WO2019155002A1 (fr) * 2018-02-08 2019-08-15 Institut Pasteur Procédés et compositions anti-prevotella bactériocine
CN116574160B (zh) * 2023-05-10 2024-06-28 华中农业大学 一种猪链球菌抗原蛋白及其应用
CN119978119B (zh) * 2025-04-15 2025-06-10 吉林大学 一种抗单增李斯特菌MurA蛋白的纳米抗体及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686896A1 (fr) * 1992-01-31 1993-08-06 Pasteur Institut Mutant attenue de listeria monocytogenes; souche recombinante de listeria monocytogenes, utilisation comme vecteurs heterologues d'antigenes vaccinal et utilisation comme vaccin ou composition diagnostique.
WO2000004156A2 (fr) * 1998-07-14 2000-01-27 University Of Hawaii Sondes specifiques aux serotypes pour la listeria monocytogenes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183957B1 (en) * 1998-04-16 2001-02-06 Institut Pasteur Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686896A1 (fr) * 1992-01-31 1993-08-06 Pasteur Institut Mutant attenue de listeria monocytogenes; souche recombinante de listeria monocytogenes, utilisation comme vecteurs heterologues d'antigenes vaccinal et utilisation comme vaccin ou composition diagnostique.
WO2000004156A2 (fr) * 1998-07-14 2000-01-27 University Of Hawaii Sondes specifiques aux serotypes pour la listeria monocytogenes

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
DATABASE SWALL 1 March 2001 (2001-03-01), HAIN, T. ET AL.: "Internalin B precursor", XP002187030 *
DRAMSI, S. ET AL.: "Identification of four new members of the internalin multigene family of Listeria monocytogenes EGD", INFECTION AND IMMUNITY, vol. 65, no. 5, May 1997 (1997-05-01), pages 1615 - 1625, XP002104784 *
GOEBEL W ET AL: "Hemolysin from Listeria --biochemistry, genetics and function in pathogenesis.", INFECTION, (1988) 16 SUPPL 2 S149-56., XP001015701 *
JEFFREY G. LAWRENCE ET AL.: "The Cobalamine (Coenzyme B12) biosynthetic genes of Escherichia coli", JOURNAL OF BACTERIOLOGY, vol. 177, no. 22, November 1995 (1995-11-01), pages 6371 - 6380, XP002187029 *
JOHN R. ROTH ET AL.: "Characterization of the Cobalamin (Vitamin B12) biosynthetic genes of Salmonella typhimurium", JOURNAL OF BACTERIOLOGY, vol. 175, no. 11, June 1993 (1993-06-01), pages 3303 - 3316, XP001042332 *
PROGRAM OF GENOME 2000, Retrieved from the Internet <URL:http://www.pasteur.fr/recherche/unites/gmp/Gmp_conf_agenda.html> [retrieved on 20010808] *
RACHEL NOWAK: "Bacterial genome sequence bagged", SCIENCE, vol. 269, 28 July 1995 (1995-07-28), DC, pages 468 - 470, XP002174835 *
See also references of EP1278853A2 *
VON BOTH U ET AL: "Physical and genetic map of the Listeria monocytogenes EGD serotype 1/2a chromosome.", FEMS MICROBIOLOGY LETTERS, (1999 JUN 15) 175 (2) 281-9., XP001015697 *
YOSHIDA K ET AL: "CLONING AND NUCLEOTIODE SEQUENCING OF A 15 KB REGION OF THE BACILLUS SUBTILIS GENOME CONTAINING THE IOL OPERON", MICROBIOLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, READING, GB, vol. 140, 1994, pages 2289 - 2298, XP000999339, ISSN: 1350-0872 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Also Published As

Publication number Publication date
US20060078901A1 (en) 2006-04-13
EP1278853A2 (fr) 2003-01-29
JP2004507217A (ja) 2004-03-11
CA2404988A1 (fr) 2001-10-18
AU2001254857A1 (en) 2001-10-23
WO2001077335A2 (fr) 2001-10-18

Similar Documents

Publication Publication Date Title
WO2001077335A3 (fr) Genome de listeria monocytogenes, polypeptides et utilisations
IL148091A0 (en) Methods and compositions for linear isothermal amplification of polynucleotide sequences
AU6872501A (en) Multiply-primed amplification of nucleic acid sequences
WO2005047511A3 (fr) Expression bacterienne d&#39;inhibiteurs de protease et variants de ceux-ci
WO2003064615A3 (fr) Reduction d&#39;amplifications dependantes d&#39;acides nucleiques non vises: amplification de sequences d&#39;acide nucleique repetitif
WO2005044836A3 (fr) Composes nucleotidiques macromoleculaires et leurs procedes d&#39;utilisation
IL154689A0 (en) Compositions containing nucleic acid primers or constructs and methods for detecting nucleic acids using the same
WO2007062160A3 (fr) Procedes et compositions de sequençage d&#39;un acide nucleique
WO2001047944A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d&#39;utilisation correspondants
WO2002026789A3 (fr) Sequences nucleotidiques mediatrices de la fertilite male et procede d&#39;utilisation associe
WO2004031210A3 (fr) Constructions optimisees a plusieurs epitopes et utilisations de ces dernieres
MXPA03006984A (es) Secuencia de nucleotidos que median la fertilidad masculina y metodo de uso de la misma.
WO2001077334A3 (fr) Genome de lactococcus lactis, polypeptides et utilisations
AU2001269575A1 (en) Nucleic acid sequences and proteins involved in cellular senescence
WO2002034942A3 (fr) Matieres et procedes relatifs a l&#39;amplification et a la definition du profil de l&#39;acide nucleique
WO2003035889A3 (fr) Compositions et procedes permettant de detecter des bacteries
WO2002006508A3 (fr) Cgtase et sequence d&#39;adn codant celle-ci
AU2002220697A1 (en) Isolated luciferases lu164, lual and lu22, and the use of the same
DE60029325D1 (en) Typ ii dns polymerase aus pyrococcus abyssi
WO2003059262A3 (fr) Methode et composition de traitement et de prevention d&#39;infections par vih et du sida
WO2001048245A3 (fr) Acides nucleiques contenant des polymorphismes de nucleotides simples, et procedes d&#39;utilisation correspondants
WO2001040521A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d&#39;utilisation correspondants
AU2001293821A1 (en) Nucleotide sequences which code for the dead gene
WO2001085965A3 (fr) Vecteurs pour procedes de sequencage d&#39;adn a base de transposon
WO2002006487A3 (fr) Sequences de regulation a partir de cellules meristematiques

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2404988

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001927973

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001927973

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001927973

Country of ref document: EP